Paul David Bach serves as Executive at Genesis Healthcare, Inc., where they oversee executive responsibilities. Since joining the company, Paul David Bach has executed 16 insider transactions totaling $108.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 15, 2021 involved selling 66,598 shares valued at $16.0K.
Paul David Bach currently holds 952,089 shares of Genesis Healthcare, Inc. (GEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul David Bach has been a net seller of GEN stock. They have purchased $0 and sold $108.7K worth of shares.
Paul David Bach's most recent insider trade was on May 15, 2021, when they sold 66,598 shares at $0.24 per share.
Get notified when new Form 4 filings are submitted
| $0.96 |
| Discretionary |
| Jun 2, 2020 | GEN | $0 | Award | 205,000 | $N/A | Discretionary |
| May 20, 2020 | GEN | $12.9K | Sale | 20,781 | $0.62 | Discretionary |
| Jun 12, 2019 | GEN | $14.5K | Sale | 12,418 | $1.17 | Discretionary |
| Jun 3, 2019 | GEN | $10.0K | Sale | 8,616 | $1.16 | Discretionary |
| May 20, 2019 | GEN | $13.8K | Sale | 11,540 | $1.20 | Discretionary |
| May 14, 2019 | GEN | $0 | Award | 204,500 | $N/A | Discretionary |
| Feb 11, 2019 | GEN | $0 | Other | 5,388 | $N/A | Discretionary |
| Dec 20, 2018 | GEN | $0 | Other | 152,722 | $N/A | Discretionary |
| Jun 12, 2018 | GEN | $13.1K | Sale | 5,735 | $2.28 | Discretionary |
| Jun 6, 2018 | GEN | $0 | Award | 185,900 | $N/A | Discretionary |
| Jun 5, 2018 | GEN | $22.2K | Sale | 10,131 | $2.19 | Discretionary |
| Jun 14, 2017 | GEN | $10.6K | Sale | 6,100 | $1.73 | Discretionary |
| Jun 7, 2017 | GEN | $4.5K | Sale | 2,769 | $1.61 | Discretionary |
| May 30, 2017 | GEN | $0 | Award | 148,750 | $N/A | Discretionary |